Cyclophilin D (CypD), a regulator of the mitochondrial membrane permeability transition pore (PTP), enhances Ca 2ϩ -induced mitochondrial permeabilization and cell death in the brain. However, the role of CypD in hypoxic-ischemic (HI) brain injury at different developmental ages is unknown. At postnatal day (P) 9 or P60, littermates of CypD-deficient [knock-out (KO)], wild-type (WT), and heterozygous mice were subjected to HI, and brain injury was evaluated 7 d after HI. CypD deficiency resulted in a significant reduction of HI brain injury at P60 but worsened injury at P9. After HI, caspase-dependent and -independent cell death pathways were more induced in P9 CypD KO mice than in WT controls, and apoptotic activation was minimal at P60. The PTP had a considerably higher induction threshold and lower sensitivity to cyclosporin A in neonatal versus adult mice. On the contrary, Bax inhibition markedly reduced caspase activation and brain injury in immature mice but was ineffective in the adult brain. Our findings suggest that CypD/PTP is critical for the development of brain injury in the adult, whereas Bax-dependent mechanisms prevail in the immature brain. The role of CypD in HI shifts from a predominantly prosurvival protein in the immature to a cell death mediator in the adult brain.
Introduction
The mechanisms underlying cell damage and the ensuing cell death after hypoxia-ischemia (HI) of the brain remain unclear. Mitochondrial permeabilization (MP) plays an important role as an event that marks the point of no return in multiple pathways to cell death through at least two alternative routes. The first relies on the opening of the permeability transition pore (PTP) in the inner mitochondrial membrane, a process enhanced by cyclophilin D (CypD) and prevented by the CypD inhibitor cyclosporine A (CsA); the second involves proapoptotic members of the Bcl-2 protein family and is thought to be independent of the PTP, often based on the lack of inhibition by CsA. Both mechanisms, which are not mutually exclusive, are involved in the ensuing release of apoptogenic proteins from mitochondria (Scorrano et al., 1997; Zamzami et al., 2005; Zoratti et al., 2005; Bernardi et al., 2006) . However, the exact role of and interaction between these mechanisms in neuronal cell death in response to HI is debated. It has been shown previously that HI in the immature brain induces MP (Puka-Sundvall et al., 2001 ) with the release of proapoptotic proteins (Wang et al., 2004b) , leading to the initiation of both caspase-dependent (Wang et al., 2001 ) and apoptosis-inducing factor (AIF)-dependent cell death . However, and contrary to the situation in the adult brain (Uchino et al., 1995; Matsumoto et al., 1999) , CsA fails to protect the neonatal brain after HI (Puka-Sundvall et al., 2001 ). This finding suggests that PTP-mediated MP is not involved in HI injury in the immature brain. Alternatively, CsA, which requires P-glycoproteinmediated active uptake into the CNS (Sakata et al., 1994) , is not transferred across the immature blood-brain barrier to the same extent as in the adult. Significant alterations in Bcl-2 family protein expression after neonatal HI have also been noted (Northington et al., 2001) , and the proapoptotic versus antiapoptotic Bcl-2 family protein balance seems critical for the development of neonatal HI injury (Parsadanian et al., 1998; Gibson et al., 2001; Hallin et al., 2006; Ness et al., 2006) . CypD, a regulator of the PTP, is important in necrotic cell death triggered by ischemia/reperfusion injury in the adult brain (Khaspekov et al., 1999; Schinzel et al., 2005; Rasola and Bernardi, 2007) , whereas the role of the CypD-regulated PTP in HI injury of the immature brain is still unclear. The aim of this study was to examine a possible protective role of CypD ablation and the relative contributions of mitochondrial dysfunction, opening of the PTP, and the proapoptotic Bcl-2 family protein Bax in HI brain damage in early postnatal life, an issue with important implications for human perinatal brain diseases.
Materials and Methods
Animals. Wild-type (WT) (C67BL/6J) and CypD knock-out (KO) mice were originally from Oregon Health and Sciences University (Portland, OR). Littermate animals with mixed genotypes, including CypD homozygous, heterozygous mutant (Het), and WT mice, were used for experiments. All mice were housed with a 12 h light/dark cycle. Ad libitum access to a standard laboratory chow diet (B & K, Solna, Sweden) and drinking water was provided. All animal experimentation was approved by the Ethical Committee of Gothenburg University (ethical number 314-2005, 269-2006) .
Genotyping. The genotype of mice was determined by PCR of genomic DNA obtained from mouse tails according to a method described previously . The WT allele was detected using a forward primer (5Ј-GCA TCG ATG CGA CAG CGA TGC TAG CGC TGC-3Ј) and a reverse primer (5Ј-ATT CCC TGT GTC TCC TCT TAG-3Ј). To detect the mutant allele, a forward primer (5Ј-GCT ATC GTG GCT GGC CAC GAC G-3Ј) and a reverse primer (5Ј-GGC GAT ACC GTA AAG CAC GAC G-3Ј) were used. CypD KO mice were identified by the presence of a single 550 bp DNA band. WT mice were identified by a single 540 bp product. Het mice were identified by the presence of both bands.
HI procedure. At postnatal day (P) 9 or P60, littermates of CypD KO, WT, and Het of both genders were anesthetized with halothane (3.0% for induction and 1.0 -1.5% for maintenance) in a mixture of nitrous oxide and oxygen (1:1). The left common carotid was ligated with prolene sutures. Mice were returned to the cage and allowed to recover for 1 h and were subsequently placed in an incubator perfused with a humidified gas mixture (10.00 Ϯ 0.01% oxygen in nitrogen) at 36°C for 40 min (P9) or 30 min (P60) to acquire a similar extent of injury (Vannucci et al., 2001; Zhu et al., 2005) . After hypoxic exposure, the pups were returned to their dam until they were killed. Different hypoxia times were chosen based on the fact that animals have different reactions to this HI model according to their age, as shown previously (Vannucci et al., 2001; Zhu et al., 2005; Lafemina et al., 2006) . Therefore, the duration of hypoxia must be varied for individual ages to achieve an adequate, consistent degree of brain damage with minimal mortality. Sham surgery (5 min of anesthesia and cervical incision and suture) did not present significant differences compared with naive controls with respect to energy and glycolytic metabolites in the brain, acid base/blood gas status (our unpublished data), expression of immediate early genes (Gubits et al., 1993) , and apoptosis (Grafe, 1994) ; therefore, we used naive controls without sham surgery as normal controls in the present study.
Assessment of brain damage. Seven days after HI, mice were deeply anesthetized and perfusion fixed with 5% formaldehyde in 0.1 M PBS. The brains were rapidly removed and immersion fixed in 5% formaldehyde at 4°C for 24 h. After dehydration with graded ethanol and xylene, the brains were paraffin embedded and cut into 6 m frontal sections. Every 100th section was stained for microtubule-associated protein-2 (MAP2) (clone HM-2, 1:2000; Sigma), and volumes of total tissue loss in different brain regions were evaluated as described previously (Wang et al., 2004a,b) by a person unaware of the HI groups. Briefly, areas displaying loss of MAP2 staining were measured using Micro Image (Olympus), and the volumes were calculated according to the Cavalieri Principle using the following formula: V ϭ SA ϫ p ϫ T, where V is the total volume, SA is the sum of the areas measured, p is the inverse of the sections sampling fraction, and T is the section thickness. Total tissue loss was calculated by subtracting the MAP2-positive volume of the ipsilateral hemisphere from the contralateral hemisphere.
Sample preparation for caspase activity assays and immunoblotting. Mice were killed at 1.5, 3, 6, or 24 h after HI (n ϭ 6 per group). Control animals were killed on P3, P9, P21, or P60 (n ϭ 6 per age). The brains were rapidly dissected out on a bed of ice. Ice-cold isolation buffer was added [15 mM Tris-HCl, pH 7.6, 320 mM sucrose, 1 mM DTT, 1 mM MgCl 2 , 3 mM EDTA-K, and 0.5% protease inhibitor mixture (P8340; Sigma)], and homogenization was performed gently by hand (to preserve mitochondrial integrity) in a 2 ml glass/glass homogenizer (VWR International). The mitochondrial, cytosolic, and nuclear fractions were separated according to a method described previously . Briefly, the homogenates were centrifuged at 800 ϫ g at 4°C for 10 min. The pellets were washed in homogenizing buffer and recentrifuged, producing a crude nuclear pellet (P 1 ). The supernatant was further centrifuged at 9200 ϫ g for 15 min at 4°C, producing a crude mitochondrial fraction in the pellet (P 2 ) and a cytosolic fraction in the supernatant (S). All fractions were stored at Ϫ 80°C. S fractions were used for caspase activity assays. P 2 and S fractions were used for immunoblotting.
Caspase activity assays. Caspase activity was measured as described previously (Wang et al., 2001) . Briefly, cleavage of Ac-DEVD-AMC [acetyl-Asp-Glu-Val-Asp-(4-methyl-coumaryl-7-amide)] (for caspase-3-like activity; Peptide Institute), Ac-VDVAD-AFC (acetyl-Val-AspVal-Ala-Asp-7-amino-4-trifluoromethylcoumarin) (for caspase-2), and Ac-LEHD-AFC (acetyl-Leu-Glu-His-Asp-7-amino-4-trifluoromethylcoumarin) (for caspase-9) (Enzyme Systems Products) was measured at 37°C using the SpectraMax Gemini Microplate Spectrofluorometer (Molecular Devices) with the appropriate excitation and emission wavelengths (excitation wavelength 380 nm and emission wavelength 460 nm for caspase-3; excitation wavelength 400 nm and emission wavelength 505 nm for caspase-2 and caspase-9) and expressed as picomoles 7-amino-4-methylcoumarin (for caspase-3) or 7-amino-4-trifluoromethylcoumarin (for caspase-2 and caspase-9) released per milligram of protein and minute.
Immunoblotting. Immunoblotting was performed as described previously . Briefly, after blocking with 30 mmol/L TrisHCl, pH 7.5, 100 mmol/L NaCl, and 0.1% Tween 20 containing 5% fat-free milk powder for 1 h at room temperature, the membranes were incubated with primary antibodies: adenine nucleotide translocase (N-19, sc-9299), AIF (D-20, sc-9416), and Bax (N-20, sc-493) (all from Santa Cruz Biotechnology), CypD (PA1-028; AH Bioreagents), actin (A2066; Sigma), cytochrome oxidase 1 (Cox1) (A21344; Invitrogen), and cytochrome c (cyt c) (556433; BD PharMingen) at room temperature for 1 h, followed by an appropriate peroxidase-labeled, secondary antibody (Vector Laboratories) for 30 min at room temperature. Immunoreactive species were visualized using the Super Signal Western Dura substrate (Pierce) and an LAS 1000-cooled CCD camera (Fujifilm). Immunoreactive bands were quantified using the Image Gauge software (Fujifilm).
Immunohistochemistry and immunofluorescence staining. Mice were killed at 6 or 24 h after HI (n ϭ 6 per group). These time points were chosen because our previous work (Zhu et al., , 2005 has shown that immunohistochemical expression of AIF, cyt c, and caspase-3 was increased at these time points. Immunohistochemistry and immunofluorescence stainings were performed as described previously . Briefly, nonspecific binding was blocked for 30 min with 4% horse, goat, or donkey serum (depending on the species used to raise the secondary antibody) in PBS. The following primary antibodies were used: anti-AIF (1:1000, D-20, sc-9416; Santa Cruz Biotechnology), cyt c (1:500, 556433; BD PharMingen), and MAP2 (1:2000). After incubating the primary antibodies for 1 h at room temperature, the appropriate, biotinylated secondary antibodies (all from Vector Laboratories) were added for 1 h at room temperature. Visualization was performed using Vectastain ABC Elite with 0.5 mg/ml 3,3Ј-diaminobenzidine enhanced with 15 mg/ml ammonium nickel sulfate, 2 mg/ml ␤-D-glucose, 0.4 mg/ml ammonium chloride, and 0.01 mg/ml ␤-glucose oxidase (all from Sigma). For the immunofluorescence staining, primary antibodies used were as follows: cyt c and anti-active forms of caspase-3 (1:100, 557035; BD PharMingen) or AIF (1:1000). Secondary antibodies used were donkey anti-mouse 488 (green, 1:500) and donkey anti-rabbit 546 (red, 1:500), and sections were mounted with 4Ј, 6Ј-diamidino-2-phenylindole (DAPI) (Invitrogen) medium. Sections were analyzed under an Olympus BX60 fluorescence microscope equipped with an Olympus DP50 cooled digital camera, and images were collected and processed using Olympus Micro Image (version 4.0).
Electron microscopy. Brain mitochondria were isolated from normal WT and CypD KO mice of P9 and P60 (n ϭ 2 per group) according to the method described above (see Sample preparation for caspase activity assays and immunoblotting) and were fixed with a mixture of 2% paraformaldehyde, 2.5% glutaraldehyde, and 0.02% sodium azide in 0.05 M sodium cacodylate, embedded in epoxy resin (Agar 100), sectioned and stained with lead citrate and uranyl acetate, and examined with a Zeiss 912AB electron microscope equipped with a MegaView III camera (Soft Imaging Systems) for digital image capture.
Measurement of mitochondrial Ca 2ϩ uptake. Mitochondria were isolated by centrifugation at 2000 ϫ g for 3 min; the supernatant was centrifuged at 12,000 ϫ g for 6 min. After washing, the resulting pellet was resuspended in isolation buffer (in mM: 225 mannitol, 75 sucrose, and 5 HEPES, pH 7.4). The Ca 2ϩ retention capacity (CRC) of mitochondrial preparations was assessed fluorimetrically in the presence of the Ca 2ϩ indicator Calcium Green-5N (Invitrogen) with a PerkinElmer Life Sciences LS50B spectrofluorimeter exactly as described previously (Fontaine et al., 1998 ) (see figure legends). The instruments were equipped with magnetic stirring and thermostatic control. The incubation conditions are specified in the figure legends.
Bax inhibition experiments. Five microliters of Bax-inhibiting peptide (BIP) V5 (5 mg/ml; catalog #196810; Calbiochem) or BIP negative control (BIPN) (5 mg/ml; catalog #196811; Calbiochem) dissolved in saline was intracerebroventricularly injected immediately before hypoxia (n ϭ 6 in each group) according to a method described previously using a syringe attached to a microinjection pump (CMA) at a speed of 1 l/min. In pilot experiments, injections of blue dye were performed to find the appropriate location. Mice were killed at 24 h after HI, i.e., a time when most commonly used apoptosis markers including caspase-3 activation reach a maximum level in this model. The gross morphology brain injury score was evaluated according to a method modified from the original description by Yager et al. (1992) , which has been found to correlate well with tissue volume loss (Wang et al., 2004a) . Briefly, after dissecting out the brain, the degree of injury was evaluated by inspection of the brain surface according to the following scale: grade 0, normal, equal size of the two hemispheres and no visible white lesion; grade 1, a small white lesion; grade 2, hypotrophy and large cysts in the ipsilateral hemisphere; grade 3, only parasagittal brain tissue remains in the ipsilateral hemisphere; and grade 4, total loss of the ipsilateral hemisphere. Cytosolic cell fractions were separated as described above (see Sample preparation for caspase activity assays and immunoblotting) and stored at Ϫ80°C for caspase-3 analysis. Determination of cyt c release from isolated brain mitochondria. Brain mitochondria were isolated according to the method described above (see Sample preparation for caspase activity assays and immunoblotting). The Bcl-2 homology 3 (BH3) peptide [with the sequence 53DAST-KKLSECLKRIGDELDSNME LQRMIAAVDTD86, as described previously (Polster et al., 2003) ] and the control BH3 peptide that had identical sequences except for a single substitution of arginine for glycine at position 67 (BH3 G67R) were synthesized by Sigma. Full-length recombinant Bax was from Abnova (H00000581-P01). According to a method described previously (Polster et al., 2003) , isolated mouse brain mitochondria (0.5-1 mg/ml final concentration) were suspended in 0.25 ml of KCl assay medium supplemented with 4 mM MgCl 2 , 3 mM ATP, 0.8 mM ADP, 250 M EGTA, 5 mM succinate, and 2 M rotenone and incubated at 30°C. Bax (100 nM) or vehicle control for Bax was also included when indicated. BH3 peptide or control BH3 peptide (each at 60 M) was added after 2 min of incubation. At 16 min after the addition of BH3 peptide or vehicle control, mitochondria were pelleted by centrifugation at 13,400 ϫ g for 5 min. For quantitative comparisons, the release of cyt c in the supernatant was assayed using an ELISA kit (MCTC0; R & D Systems) according to the instructions of the manufacturer.
Statistics. The Student's t test was used when comparing two groups, whereas ANOVA followed by Fisher's PLSD post hoc test was used when comparing three or more groups. The Mann-Whitney test was used to compare gross morphology. p Ͻ 0.05 was considered statistically significant. All data are expressed as mean Ϯ SEM.
Results

Effects of CypD deficiency on HI brain injury in neonatal versus adult mice
Analysis of brain injury in P9 WT, CypD KO, and Het mice revealed a more pronounced damage in CypD KO mice (total tissue loss, 20.6 Ϯ 3.5 mm 3 ; n ϭ 19) than in WT mice (10.5 Ϯ 1.7 mm 3 ; n ϭ 16; p ϭ 0.017) 7 d after HI (Fig. 1 A, C) . On the contrary, and in keeping with a previous study (Schinzel et al., 2005) , absence of CypD resulted in a significant decrease in HI brain injury at P60. The total tissue loss in P60 mice was 2.3 Ϯ 1.9 mm 3 in KO (n ϭ 13) versus 14.3 Ϯ 4.8 mm 3 in WT mice (n ϭ 18; p ϭ 0.035) (Fig. 1 B, D) . Although brain injury and apoptosis in the immature brain has been shown previously to depend on gender (Du et al., 2004; Hagberg et al., 2004; Hurn et al., 2005; Zhu et al., 2006; Johnston and Hagberg, 2007; Nijboer et al., 2007; Renolleau et al., 2007 Renolleau et al., , 2008 , subanalysis according to sex demonstrated that the influence of CypD deficiency on brain injury in immature and adult mice did not depend on gender in our protocols (data not shown).
Effect of CypD deficiency on brain mitochondrial morphology and PTP function in neonatal versus adult mice
To investigate whether the CypD genotype differentially affected mitochondrial ultrastructure at the two ages, EM on brain mitochondria-enriched cell fractions was performed. No obvious differences in mitochondrial morphology between WT and KO mice at P9 or P60 were revealed (Fig. 2 A) . CypD was as abundant in immature as in mature brain mitochondria with the development from P3 to P60 ( p Ͼ 0.05) (Fig. 2 B, C) . ANT, a putative PTP regulator (Kokoszka et al., 2004) , over the Cox1 were expressed at slightly higher levels in mature brains (compare P21 and P60 with P3 and P9) (Fig. 2 B, C) , but the increases were not statistically significant ( p Ͼ 0.05). Neither CypD ablation nor HI influenced the expression of ANT, and HI did not alter the expression of CypD itself in the mitochondria-enriched cell fractions ( p Ͼ 0.05) (Fig. 2 D, E) . The functional properties of the PTP were evaluated in brain mitochondria prepared from P9 and P60 WT and KO mice. The CRC assay measures the threshold amount of Ca 2ϩ required to open the PTP in isolated mitochondria. As expected (Basso et al., 2005 ), brain mitochondria from both neonatal and adult KO mice were desensitized to Ca 2ϩ , requiring approximately twice the amount of Ca 2ϩ to open the PTP than mitochondria from WT animals (Fig. 3 A, B , compare traces d and dЈ, f and fЈ). Interestingly, brain mitochondria from neonatal WT mice required far more Ca 2ϩ to open the PTP than mitochondria from adult mice (Fig. 3A, compare traces d and f ) , regardless of the presence of CypD (Fig. 3A , compare traces dЈ, fЈ). CsA was a more efficient desensitizer in adult than in neonatal WT mitochondria, whereas it was ineffective in mitochondria from KO animals, as expected (Fig. 3 B, C) .
Effect of CypD deficiency on apoptotic mechanisms after HI in neonatal versus adult mice
Caspase-2, caspase-3, and caspase-9 were markedly induced in the brain after HI at P9, whereas the activation and alterations were negligible at P60 (Fig. 4 A-C) , similar to previous reports showing that there is a significant decrease in caspase activation with age (Cheng et al., 1997; Hu et al., 2000; Wang et al., 2001; Zhu et al., 2005) . At P9, caspase-2, caspase-3, and caspase-9 were all significantly more activated in KO than WT mice (Fig. 4 A-C,  left) , whereas at P60 the opposite was observed (Fig. 4 A-C,  right) . A decrease of cyt c was observed in the mitochondrial fraction, matched by an increase in the cytosolic fraction after HI at both ages. At P9, the release of cyt c at 24 h after HI was much more pronounced in KO compared with WT mice, whereas in adult mice, the opposite occurred (Fig. 5 A, D,E) . AIF decreased at 6 and 24 h after HI in the mitochondria-enriched cell fractions in both WT and KO mice at P9, but the loss was most pronounced at 24 h after HI in KO mice (Fig. 5 A, B) . AIF changes after HI in the adult brain were limited and independent of genotype ( Fig.  5 A, C) . In P9 KO mice, post-HI changes were further confirmed by immunohistochemistry (Fig. 5F ). AIF immunoreactivity translocated from mitochondria to nuclei after HI (Fig. 5F, a-h ). Double immunostaining showed that cyt c expression shifted from a weak expression in the cytosol of normal control brain cells to a much stronger staining with a diffuse cytosolic localization in cells that highly expressed the cleaved active form of caspase-3 after HI (Fig. 5F, i-p) .
Effect of CypD deficiency on Bax expression and the role of Bax inhibition in HI brain injury in neonatal versus adult mice
We next investigated the role of Bax-mediated mechanisms in HI brain injury at the two ages. In normal control brains from the WT mice, a marked decrease of mitochondrial Bax expression independent of CypD during the development from P3 to P60 was noticed (Fig. 6 A) . After HI at P9, translocation of Bax to mitochondria increased at 1.5 and 3 h in both genotypes, but the increase was more pronounced in KO than in WT individuals at 3 h (Fig. 6 B) . In brains of P60 mice, Bax expression was rather low and no obvious changes after HI were detected (data not shown). To further investigate the role of Bax in HI brain injury, a single injection of BIP was administered intracerebroventricularly immediately before HI in the WT mice. BIP reduced brain injury by 79% (brain injury score, 0.3 Ϯ 0.05 in BIP group vs 1.4 Ϯ 0.2 in BIPN group) and caspase-3 activation by 65% (Fig. 6C ) in P9 WT mice, whereas the corresponding effects were negligible in P60 WT mice on both the brain injury (brain injury score, 2.8 Ϯ 0.15 in BIP group vs 3.0 Ϯ 0.2 in BIPN group) and caspase-3 activation (Fig. 6 D) . In addition, cyt c release was assessed in vitro by adding BH3 peptide to isolated brain mitochondria in a cytosollike medium. Under these conditions, BH3 peptide induced cyt c release in both the absence and presence of exogenous full-length recombinant Bax at P9 (Fig. 7, top) , whereas at P60, BH3 peptideinduced cyt c release required the presence of exogenous Bax (Fig.  7, bottom) , as reported previously (Polster et al., 2003) , probably because the endogenous level of Bax in adult brain mitochondria was too low (Fig. 6 A) . Moreover, BH3 peptide induced a more pronounced cyt c release in KO than in WT mice in P9 brain mitochondria (Fig. 7A) . In contrast, BH3-induced cyt c release was attenuated in mitochondria from KO compared with WT mice at P60 (Fig. 7B) . Bax alone did not elicit cyt c release from isolated P9 brain mitochondria, but exogenous Bax enhanced the effect of the BH3 peptide (Fig. 7A) .
Discussion
In neurons, MP appears to be a critical event in response to HI in both the immature and the adult brain. MP triggers the release of apoptotic factors such as cyt c and AIF, proteins contributing to the propagation of the apoptotic cascade and the execution of cell death. However, the mechanism leading to MP after HI is controversial and may depend on brain maturity. The present data show that a CypD-dependent PTP is critical for the development of HI injury in the adult brain but not so important in the neonatal brain in which Bax-dependent MP is instead essential. Moreover, CypD prevents rather than enhances MP in the immature brain, because lack of CypD worsens injury (Fig. 8) . We propose that these age-dependent differences in mitochondrial responses to injury are of fundamental importance not only for mechanistic reasons but also for the selection of a neuroprotective strategy in the neonate.
CypD KO mice exhibit a normal phenotype and brain morphology, including normal cerebrovasculature (Basso et al., 2005; Schinzel et al., 2005) . Confirming this, we found an unaltered brain mitochondrial morphology in CypD-deficient mice. Given the critical role of apoptosis during embryogenesis, these data suggest that CypD is not essential for physiological apoptosis in the early stages of development. Furthermore, various cells isolated from CypD KO mice undergo apoptosis normally in response to various stimuli, including Bax activation (Baines et al., 2005; Nakagawa et al., 2005) . Several studies have revealed CypD to be an important PTP regulator critical for Ca 2ϩ -mediated, CsA-inhibited MP induction and necrosis (for review, see Rasola and Bernardi, 2007) . In the present study, we found that the lack of CypD conferred dramatic protection against HI-induced brain injury in adult mice, which agrees with a pivotal role of the CypDdependent PTP in adult ischemic stroke (Schinzel et al., 2005) . Caspase activation after HI in P60 animals remained relatively low with the caspase-3 target ␣-fodrin not being cleaved (data not shown), suggesting that CypD-dependent, apoptosisindependent processes are of central importance in oxidative stress-induced cell death in the adult (Baines et al., 2005; Nakagawa et al., 2005) . In contrast, the apoptotic cascade is thought to play a major role in neonatal HI-induced brain injury (Cheng et al., 1997; Hu et al., 2000; Zhu et al., 2005) . In our study, CypD , f, g ). cyt c in a normal control brain (i, k, l ) and 24 h after HI (j, n, o). Note the more condensed apoptotic phenotype of the nuclei in h. c, f, AIF staining; e, h, DAPI nuclei staining; d, g, merged pictures of AIF (green) and DAPI (blue); k, n, cyt c staining; m, p, caspase-3 staining; l, o, merged pictures of cyt c (green) and caspase-3 (red). Scale bars, 10 m.
deficiency resulted in significantly increased HI brain injury at P9, partly agreeing with our previous finding that the immature brain, in contrast to the adult brain, is not protected by the CypD inhibitor CsA (Puka-Sundvall et al., 2001) . CypD expression in brain mitochondria was high in both neonates and adults, making the differences in HI sensitivity unlikely to be attributable to age-dependent differences in CypD levels (Eliseev et al., 2007) . Instead, the results may indicate that the CypD-dependent PTP in neonatal HI is not present to the same extent as in adult HI or that other factors regulating PTP activity are differentially expressed during development. Notably, there was a significant difference in brain injury between WT and Het at P9 (but not between Het and KO), suggesting that there is a threshold amount of CypD that is required to inhibit mitochondrial permeabilization and reduce injury in vivo. The fact that no difference was found between Het and KO individuals supports our choice to use only WT and KO (rather than Het) in the mechanistic characterization (Figs. 2-7) .
The in vitro functional mitochondria experiments demonstrated that brain mitochondria from neonatal mice required higher levels of Ca 2ϩ than those from adults to open the PTP. In addition, these assays showed that neonatal brain mitochondria did not respond to the PTP inhibitor CsA as efficiently as adult WT mitochondria, in keeping with the observation that CsA does not protect the brain of neonatal rats (Puka-Sundvall et al., 2001) and indicate that, after HI, PTP opening does not contribute to MP in the neonatal to the same extent as in the adult brain. Indeed, we discovered that the PTP in adult brain mitochondria displayed a lower Ca 2ϩ -induced opening threshold and a higher CypD dependence than in neonatal mitochondria, indicating that PTP induction only plays a critical role in ischemia-induced brain injury in the adult. Other age-dependent differences may affect MP in the complex situation of ischemia in vivo (Robertson et al., 2004) . Spreading depression waves of Ca 2ϩ uptake seem to be less prominent in the immature brain (Takita et al., 2004) , in which also the anoxic depolarization with concomitant Ca 2ϩ uptake is slower. Moreover, the primary energy depletion in the immature brain is much slower, with a lower accumulation of ADP/AMP and phosphate ion (Pi) and thus weaker stimuli for the opening of the PTP (Hansen and Nordstrom, 1979) .
Brain injury in P9 mice was actually increased rather than . MP is center stage in HI brain injury at all ages, but the mechanism of MP shifts during brain development. In neonatal mice, Bax-mediated permeabilization leading to AIFand caspase-dependent cell death, which is inhibited by CypD, predominates. In contrast, in adult animals, cell death depends on CypD-regulated and PTP-mediated mitochondrial permeabilization.
unaffected in CypD-deficient mice. In other words, Baxdependent mechanisms of MP in the immature brain are inhibited rather than enhanced by CypD, suggesting that CypD somehow protects the immature brain. The increased brain injury in P9 KO mice was accompanied by an enhanced translocation of Bax to mitochondria compared with age-matched WT controls.
In vitro, the BH3 peptide mimicking Bax action induced more cyt c release in isolated mitochondria from P9 KO than from WT mice. In contrast, similar assays of BH3 peptide-mediated cyt c release showed an enhanced release in WT compared with KO mice at P60, which strongly supports the in vivo finding. These results suggest that CypD modulates Bax activity and thereby the induction of MP and cell death. Indeed, some in vitro studies show that CypD overexpression desensitizes cells from apoptotic stimuli (Liu et al., 2002) and even suppresses apoptosis under some conditions (Machida et al., 2006) . However, the detailed mechanisms involved need to be further investigated. The fact that Bax inhibition substantially reduced HI injury in neonatal but not in adult mice strongly indicates that Baxmediated MP predominates in the immature brain and that novel Bax inhibitors may have therapeutic potential (Kinnally and Antonsson, 2007) . The widespread expression of Bax and its ability to heterodimerize with multiple Bcl-2 family members (Knudson et al., 1995) as well as the fact that Bax/Bak double-knock-out mice display defective apoptosis in multiple tissues (Roset et al., 2007) suggest that it may have a central role in regulating apoptosis in early development. In addition, very low levels of Bax were present in adult brain mitochondria compared with those of immature mice (Fig. 6 A) (Vekrellis et al., 1997; Polster et al., 2003; Soane et al., 2008) . In vitro, BH3 peptide did not induce cyt c release without the presence of exogenous Bax in isolated mitochondria from adult in contrast to those from neonatal mice, indicating that immature brain mitochondria are much more prone to Bax-mediated MP.
In conclusion, HI brain injury depends on Bax-mediated but not on CypD/PTP-dependent MP in the neonatal brain, whereas CypD/PTP-mediated MP is critical in the adult. Thus, during development, CypD shifts from a prosurvival molecule to a cell death enhancer after HI-induced brain injury. These data further corroborate the fundamental difference between the responses of the immature versus the adult brain to HI, which will be decisive in the choice of molecular targets for neuroprotection in the future.
